NCT03614494View on ClinicalTrials.gov

Piroxicam and Levonorgestrel Co-treatment for Emergency Contraception

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

860

Participants

Timeline

Start Date

August 20, 2018

Primary Completion Date

October 5, 2022

Study Completion Date

October 5, 2022

Conditions
Emergency Contraception
Interventions
DRUG

Piroxicam 40 mg

Additional co-treatment

DRUG

Levonorgestrel 1.5mg

Standard treatment

Trial Locations (2)

Unknown

Queen Mary Hospital, Hong Kong

The Family Planning Association of Hong Kong, Hong Kong

All Listed Sponsors
collaborator

The Family Planning Association of Hong Kong

OTHER

lead

Dr. Hang Wun Raymond Li

OTHER

NCT03614494 - Piroxicam and Levonorgestrel Co-treatment for Emergency Contraception | Biotech Hunter | Biotech Hunter